Latest Breaking News On - Slaidburn crescent - Page 1 : comparemela.com

Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company s wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.

United kingdomMarksans pharmaRelonchem limited for fluoxetineMarksans pharma ltdMarksans pharma limited reutersDruggists ltdSons coPharma limitedMarket authorisationRelonchem limitedGifford houseSlaidburn crescentMarksans pharma limited